Celanese Corporation $CE Shares Acquired by Amundi

Amundi increased its stake in shares of Celanese Corporation (NYSE:CEFree Report) by 81.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 381,615 shares of the basic materials company’s stock after buying an additional 171,061 shares during the quarter. Amundi’s holdings in Celanese were worth $23,134,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Marshall Wace LLP grew its stake in shares of Celanese by 706.8% in the 2nd quarter. Marshall Wace LLP now owns 819,833 shares of the basic materials company’s stock valued at $45,361,000 after purchasing an additional 718,218 shares during the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Celanese by 42.1% during the second quarter. Baird Financial Group Inc. now owns 7,768 shares of the basic materials company’s stock worth $430,000 after purchasing an additional 2,303 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Celanese by 144.9% during the second quarter. EverSource Wealth Advisors LLC now owns 1,276 shares of the basic materials company’s stock worth $71,000 after purchasing an additional 755 shares during the period. Quantbot Technologies LP grew its position in Celanese by 187.1% in the 2nd quarter. Quantbot Technologies LP now owns 92,834 shares of the basic materials company’s stock valued at $5,137,000 after buying an additional 60,497 shares during the last quarter. Finally, Lido Advisors LLC acquired a new position in Celanese in the 2nd quarter valued at $524,000. 98.87% of the stock is owned by hedge funds and other institutional investors.

Celanese Trading Up 7.6%

Shares of Celanese stock opened at $43.25 on Thursday. The company has a 50-day moving average of $40.29 and a two-hundred day moving average of $47.45. Celanese Corporation has a 12-month low of $35.13 and a 12-month high of $75.84. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 2.66. The stock has a market cap of $4.74 billion, a PE ratio of -1.53 and a beta of 1.13.

Celanese (NYSE:CEGet Free Report) last released its quarterly earnings results on Thursday, November 6th. The basic materials company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.07. Celanese had a positive return on equity of 9.87% and a negative net margin of 31.85%.The business had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.51 billion. During the same quarter in the prior year, the firm posted $2.44 EPS. The company’s revenue was down 8.6% compared to the same quarter last year. Celanese has set its Q4 2025 guidance at 0.850-1.000 EPS. On average, research analysts anticipate that Celanese Corporation will post 8.79 EPS for the current fiscal year.

Celanese Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 12th. Stockholders of record on Tuesday, October 28th were given a $0.03 dividend. The ex-dividend date was Tuesday, October 28th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.3%. Celanese’s dividend payout ratio (DPR) is currently -0.42%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CE. Robert W. Baird lowered their target price on shares of Celanese from $67.00 to $50.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. KeyCorp reduced their price objective on shares of Celanese from $77.00 to $70.00 and set an “overweight” rating for the company in a research report on Wednesday, August 13th. Citigroup boosted their target price on Celanese from $53.00 to $60.00 and gave the stock a “buy” rating in a research report on Tuesday, November 11th. UBS Group increased their target price on Celanese from $48.00 to $49.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 12th. Finally, Evercore ISI decreased their price target on Celanese from $75.00 to $45.00 and set an “in-line” rating on the stock in a research note on Tuesday, November 11th. Seven research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $54.78.

Get Our Latest Stock Analysis on Celanese

Celanese Profile

(Free Report)

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.

Read More

Want to see what other hedge funds are holding CE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celanese Corporation (NYSE:CEFree Report).

Institutional Ownership by Quarter for Celanese (NYSE:CE)

Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.